Ubrelvy (ubrogepant) is used to treat the symptoms of a migraine attack in adults and is a calcitonin gene-related peptide inhibitor (CGRP). It is approved by the United States Food and Drug Administration to treat migraine attacks. It comes in tablet form and can treat migraines with or without aura, which are sensory phenomena that can cause visual sensitivity, disturbances, and discomfort.
Medication type:
Oral
Recommended for:
✓ Acute treatment of migraine attacks with or without aura in adults
We also charge a $60 medication consultation, which includes unlimited access to our medical team for a full year.
To learn more about migraine treatment from Nurx, click here.